TY - JOUR
T1 - Clozapine Treatment in Very Early Onset Schizophrenia
AU - MOZES, TAMAR
AU - TOREN, PAZ
AU - CHERNAUZAN, NADEJDA
AU - MESTER, ROBERTO
AU - YORAN-HEGESH, RONI
AU - BLUMENSOHN, RACHEL
AU - WEIZMAN, ABRAHAM
PY - 1994
Y1 - 1994
N2 - Very early onset schizophrenic patients only partially benefit from conventional antipsychotic treatment and are at increased risk for developing tardive dyskinesia (TD). Clozapine, which lacks extrapyramidal side effects including TD, has been proved effective for adult schizophrenic patients who are resistant to other neuroleptics. Clozapine, therefore, may offer an alternative treatment for these patients. The authors report four successful trials of clozapine in children aged 10 to 12 years old with schizophrenia, the youngest group reported on to date, who were unresponsive to conventional neuroleptic treatment.
AB - Very early onset schizophrenic patients only partially benefit from conventional antipsychotic treatment and are at increased risk for developing tardive dyskinesia (TD). Clozapine, which lacks extrapyramidal side effects including TD, has been proved effective for adult schizophrenic patients who are resistant to other neuroleptics. Clozapine, therefore, may offer an alternative treatment for these patients. The authors report four successful trials of clozapine in children aged 10 to 12 years old with schizophrenia, the youngest group reported on to date, who were unresponsive to conventional neuroleptic treatment.
KW - children
KW - clozapine
KW - schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=0028157527&partnerID=8YFLogxK
U2 - 10.1097/00004583-199401000-00010
DO - 10.1097/00004583-199401000-00010
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0028157527
VL - 33
SP - 65
EP - 70
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
SN - 0890-8567
IS - 1
ER -
